Enzymaster provides a one-stop solution for the development and commercialization of innovative and sustainable enzyme catalysis technologies. With our proprietary BioEngine(r) platform and long-term experience, we offer R & D services combined with establishment of complete technology transfer packages, and manufacturing collaborations to fine chemical, pharmaceutical, and other read moreindustries.

Our portfolio includes enzyme panel screening, smart enzyme engineering, process development, enzyme preparation by fermentation, and biocatalytic manufacturing. In addition to these services, we also offer general enzyme kits that represent various enzyme classes as well as customized enzyme kits that fit to the individual biotransformation needs of our customers.

Enzymaster Deutschland GmbH, a subsidiary of Enzymaster (Ningbo) Bio-Engineering Co. Ltd., represents your partner in the international market for enzyme applications and products manufactured by biocatalytic processes.

Advancing in innovation to improve people's lives has been our mission since our establishment in 1966. We are a global company, headquartered in Barcelona, with state-of-the-art industrial sites in Spain, Mexico and China to serve our CMO customers worldwide.

We take pride in our values and reflect read morethem in everything we do: people matter, transparency and accountability. Because this is the only way we know how to do business and because, as a healthcare company, we have a huge responsibility to both people and the environment.

We are focused in developing and manufacturing small molecules, advanced intermediates, and active ingredients for our customers, always focusing on long-term partnerships. And we are committed to excellence by offering a complete range of services from the initial stages of development of an API to the manufacturing of on-going commercial supplies.

Esteve Química’s development capabilities, deep knowledge, fast adaptation to customers' requirements and regulations, technical capabilities, strategic geographical location and, particularly, commitment to excellence, allow ensuring an optimum service and reliable response whatever the scale of the project. And also allows us to continue to serve the medical needs of patients with passion and commitment.

Euroapi is focused on reinventing active ingredient solutions to sustainably meet customers' and patients' needs around the world.

We are a world leader in active pharmaceutical ingredients with some 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract read moreDevelopment and Manufacturing Organization (CDMO). [website]

Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world's largest pharmaceutical, biopharmaceutical and medical device companies. Our comprehensive service offerings include testing of drug substance, final product, intermediates, and starting materials for both read moresmall and large molecule drug products.

Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world's largest pharmaceutical, biopharmaceutical and medical device companies. Our comprehensive service offerings include testing of drug substance, final product, intermediates, and starting materials for both read moresmall and large molecule drug products.

Evonik Industries offers a full range of custom API manufacturing services as well as oral and parenteral formulation development expertise. Our global manufacturing footprint and technical expertise provides unique flexibility and problem solving capabilities to meet your most demanding project’s requirements.

As a global leader read morein HPAPI manufacturing, we can seamlessly take your project from lab scale through to large commercial multi-ton quantities. Our global development and manufacturing network provides increased flexibility to meet your demanding requirements. At our facility in Lafayette, IN, which has been producing commercial quantities of HPAPIs for two decades, we operate with OELs <0.1 µg/m3. Evonik has experienced people with the right expertise, the right equipment and the right motivation to see your high potency projects from clinical stages through commercialization.

Our offering also includes the manufacture of non-exclusive intermediates and APIs such as L-tert-leucine based building blocks, Lisinopril, Lorazepam and Nifedipin. We also offer amino acids, amino acid derivatives, and small chain peptides for parenteral or oral nutrition, or as building blocks for synthesis.

For your formulation needs, Evonik produces functional excipients for modified oral delivery (EUDRAGIT®) and bioresorbable polymers for extended release parenteral formulations or medical devices (Resomer®). We offer formulation development services for both oral and injectable forms. Evonik has expertise in solubility and bioavailability enhancement of oral formulations utilizing spray drying, hot melt extrusion and other proprietary technologies. We also have expertise in injectable extended release formulations including microsphere, gel and implants.

Custom manufacturing services for oral drug products from preclinical to clinical phases as well as parenteral drug manufacturing from clinical through drug commercialization are also offered. [website]

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company's multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, read moreand production of first-in-class and best-in-class pharmaceutical products. Evotec provides high value pipeline co-creating partnerships and solutions to all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people. The Company's sites in Europe and the USA offer highly synergistic technologies and services and operate as complementary clusters of excellence. For additional information please follow us on X/Twitter @Evotec and LinkedIn. [website]

Exemplify BioPharma provides integrated end-to-end program and/or portfolio based CMC drug development deliverables to pharmaceutical and biotech partners. Through a combination of program management and coordination, process development laboratories and the provision of CMC regulatory documentation for filing with worldwide regulatory agencies. Exemplify BioPharma is uniquely positioned read moreto deliver CMC success to partner organizations. In addition, Exemplify BioPharma provides consultation and innovative approaches to the challenges of drug development. [website]